Literature DB >> 23393669

Global prevalence and future of diabetes mellitus.

Emil Ginter1, Vlado Simko.   

Abstract

This chapter addresses the prevalence of diabetes mellitus (DM) in various countries according to geographic regions, as designated in an atlas publishedby the International Diabetes Federation in 2011. These include countries and territories in Europe, Africa, Middle East, North Africa, North America and Caribbean islands, South and Central America, South-East Asia and the Western Pacific Islands. Actual prevalence of DM (cases per 100 population) is expressed not only specifically for each individual country (national value) but more importantly, corrected by the population, age structure (comparative value) and also as an estimate of DM trend in 2030. It can be seen that in all countries (Tables 1-5) the prevalence of DM is on rise. A substantial contributing factor to the rise is the steady increase in body weight and obesity in many parts of the world. Economic stability and technological progress promote obesity in European countries, the USA and in oil producing countries such as Saudi Arabia, United Arab Emirates and Kuwait. Also environmental factors, social trends toward higher energy intake and reduced energy expenditure also have a decisive role to play in the pathogenesis of overweight and DM.

Entities:  

Mesh:

Year:  2012        PMID: 23393669     DOI: 10.1007/978-1-4614-5441-0_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  27 in total

Review 1.  Lost in translation: endoplasmic reticulum stress and the decline of β-cell health in diabetes mellitus.

Authors:  C Evans-Molina; M Hatanaka; R G Mirmira
Journal:  Diabetes Obes Metab       Date:  2013-09       Impact factor: 6.577

Review 2.  Insulin and glucagon signaling in the central nervous system.

Authors:  Beatrice M Filippi; Mona A Abraham; Jessica T Y Yue; Tony K T Lam
Journal:  Rev Endocr Metab Disord       Date:  2013-12       Impact factor: 6.514

3.  Clinical utility of insulin and insulin analogs.

Authors:  Ahter D Sanlioglu; Hasan Ali Altunbas; Mustafa Kemal Balci; Thomas S Griffith; Salih Sanlioglu
Journal:  Islets       Date:  2013-03-01       Impact factor: 2.694

4.  Resveratrol Prevents Retinal Dysfunction by Regulating Glutamate Transporters, Glutamine Synthetase Expression and Activity in Diabetic Retina.

Authors:  Kaihong Zeng; Na Yang; Duozi Wang; Suping Li; Jian Ming; Jing Wang; Xuemei Yu; Yi Song; Xue Zhou; Yongtao Yang
Journal:  Neurochem Res       Date:  2015-12-16       Impact factor: 3.996

5.  Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery.

Authors:  Moataz F Elsawy; Nermine Badawi; Hany A Khairy
Journal:  Clin Ophthalmol       Date:  2013-06-24

6.  Pre-germinated brown rice prevents high-fat diet induced hyperglycemia through elevated insulin secretion and glucose metabolism pathway in C57BL/6J strain mice.

Authors:  Kuo-Ping Shen; Chi-Long Hao; Hsueh-Wei Yen; Chun-Yen Chen; Bin-Nan Wu; Hui-Li Lin
Journal:  J Clin Biochem Nutr       Date:  2014-11-28       Impact factor: 3.114

Review 7.  Amylin at the interface between metabolic and neurodegenerative disorders.

Authors:  Thomas A Lutz; Urs Meyer
Journal:  Front Neurosci       Date:  2015-06-16       Impact factor: 4.677

Review 8.  Biomarkers in diabetic retinopathy and the therapeutic implications.

Authors:  Katarzyna Zorena; Dorota Raczyńska; Krystyna Raczyńska
Journal:  Mediators Inflamm       Date:  2013-11-07       Impact factor: 4.711

9.  Joint associations of physical activity and hypertension with the development of type 2 diabetes among urban men and women in Mainland China.

Authors:  Fei Xu; Robert S Ware; Lap Ah Tse; YouFa Wang; ZhiYong Wang; Xin Hong; Emily Ying Yang Chan; David W Dunstan; Neville Owen
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

10.  Sympathovagal imbalance contributes to prehypertension status and cardiovascular risks attributed by insulin resistance, inflammation, dyslipidemia and oxidative stress in first degree relatives of type 2 diabetics.

Authors:  Gopal Krushna Pal; Chandrasekaran Adithan; Palghat Hariharan Ananthanarayanan; Pravati Pal; Nivedita Nanda; Thiyagarajan Durgadevi; Venugopal Lalitha; Avupati Naga Syamsunder; Tarun Kumar Dutta
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.